Extensive immediate actions needed for global control of tuberculosis

NewsGuard 100/100 Score

Announcing a new article publication for Zoonoses journal. In this article the authors discuss how extensive immediate actions worldwide are required to progress toward a tuberculosis-free world.

Tuberculosis is a zoonotic disease that is caused by mycobacterium tuberculosis complex and can infect humans, livestock, and wildlife.

It spreads primarily through the respiratory tract and was the leading cause of death due to a single infectious disease before the COVID-19 pandemic. TB is a global public health emergency that has reemerged over the past few decades. Substantial efforts are needed to achieve the goals of the End TB Strategy.

The World Health Organization has estimated that approximately 9.9 million people worldwide contracted TB in 2020 and that approximately 140,000 of the 10 million new cases of active TB in 2019 were zoonotic TB. During the COVID-19 pandemic, the number of new TB diagnoses and reports decreased sharply, from 7.1 million in 2019 to 5.8 million in 2020, returning to 2012 levels far below the approximately 10 million TB cases in 2020. Simultaneously, the global decrease in the absolute number of TB deaths until 2019 was followed by an increase in 2020 in four of the six WHO regions and most of the 30 high-TB-burden countries.

Source:
Journal reference:

Huang, F & Zhao, Y., (2022) Global Control of Tuberculosis: Current Status and Future Prospects. Zoonoses. doi.org/10.15212/ZOONOSES-2021-0021.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Second-line treatment for drug-resistant tuberculosis is as effective as first-line medicines